KDM1A has been also reported as an essential regulator of leukemia stem cell potential in a murine model of human MLL-AF9 leukemia,30 with persistence of expression in associated oncogenic signaling, thereby preventing differentiation and apoptosis of leukemic cells. Here, KMT2A is linked to leukemia.